Divi's Laboratories
Dr. Kiran Divi is the Director on Board & Chief Executive Officer at Divi’s Laboratories Ltd and has been with Divi’s for the past 20 years. He officially took on the role of leading Divi’s as the CEO, starting January 2020. He oversees all the Corporate functions and Operations at their manufacturing facilities. Under his direction, Divi’s has been developing high quality business strategies and plans ensuring their alignment with the short term and long term objectives.
Prior to joining Divi’s, Dr. Divi has gained extensive knowledge and understanding of the Pharmaceutical Industry with an extra focus on the U.S. Generic Market. He has a post-graduate degree in Pharmacy from JNTU, India. He holds a Ph.D. degree from Gandhi Institute of Technology and Management, Visakhapatnam.
This person is not in any offices
Divi's Laboratories
4 followers
Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. The Company's geographical segments include India (Sales to customers within India) and other countries (Sales to customers outside India). Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life cycle and generic drug manufacturers. The Company develops carotenoids, such as Apocarotenal, Betacarotene, Lycopene, Astaxanthin and Canthaxanthin. It manufactures tert-butoxycarbonyl (BOC), Fluorenylmethyloxycarbonyl (FMOC) and Carboxybenzyl (CBZ) protected amino acids. It manufactures ligands, such as binol and binap. The Company exports its products to European and the American countries. Its manufacturing and research and development facilities are located in the State of Andhra Pradesh and Telangana in India.